All Stories

  1. ARIA 2016 executive summary: Integrated care pathways for predictive, preventive and personalized medicine across the life cycle
  2. New Suggestions in Sublingual Immunotherapy for House Dust Mite- Related Allergic Diseases
  3. Targeted therapy in severe asthma today: focus on immunoglobulin E
  4. Umeclidinium for the treatment of uncontrolled asthma
  5. Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype
  6. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience
  7. Molecular diagnosis and precision medicine in allergy management
  8. Switching treatments in COPD: implications for costs and treatment adherence